DermTech, Inc. announced that Dr. John Dobak expects to step away from his role as chief executive officer under a planned transition. Dr. John Dobak will continue to serve as chief executive officer until the earlier of the date the Board appoints a successor and September 30, 2023. The Board has initiated a comprehensive search to identify Dr. Dobak's replacement.